Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Post by Tornado69on Dec 17, 2020 4:38am
311 Views
Post# 32125995

600% gain so far, sold 2/3 and plowed winnings into HAVN !

600% gain so far, sold 2/3 and plowed winnings into HAVN !
This whole sector is going to explode as the recent memory of what pot stocks did is fresh in everyones mind. MindMed and Numiness Wellness did 10 baggers in 3 months. I sold 3/4 of my positions 600% win and put the 100k winnings into Havn Life Sciences (HAVN on TSX-V). The same team who took Aphria Inc Cannabis (which just bought out Tilray today to form the largest cannabis company in the world even bigger than Canopy Growth ) from .50 cents to 23 dollars just went public and has their pysilocibin shroom license from Health Canada to do it again. The board of directors is all government people/former Aphria/Zenabis Cannabis people ! Time to jump on these handful of winners before everyone else does ! https://havnlife.com/about/ ... time to jump on the next winners before everyone else catches on.
<< Previous
Bullboard Posts
Next >>